| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03d0f52bb4069f8a19d70dcfb697c67a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
| filingDate |
2003-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf0ced96cbf896fc881bd2598ea6798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69cece78cbb25bcef46aad8ad2b3d117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b55518a5511c14af8547a05b1b512157 |
| publicationDate |
2004-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004231623-A |
| titleOfInvention |
Threitol derivatives having iodoaryl groups |
| abstract |
An iodo compound suitable for a liposome-containing iodinated contrast medium for selectively imaging a lesion is provided. The following general formula (I): [Chemical 1] (In the formula, Ar 1 and Ar 2 each independently represent a hydrogen atom or an aryl group, but either one or both of Ar 1 and Ar 2 represents an aryl group having at least one iodine atom as a substituent. L 1 and L 2 each independently represents a divalent linking group; R 1 and R 2 each independently represent a hydrogen atom or a monovalent substituent) or a salt thereof, and Liposomes containing the compound or a salt thereof as a membrane constituent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008088064-A |
| priorityDate |
2003-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |